Support program for relatives of patients expected to die in the emergency department
Official title: A Multifaceted Intervention Strategy for Relatives of End-of-life Patients in the Emergency Department: a Cluster Randomized Trial
Run by Assistance Publique - Hôpitaux de Paris · NCT06733974 · Data updated 2026-11-12
This trial will try a multifaceted support program to reduce prolonged grief and PTSD in adults who are relatives of patients expected to die in the emergency department.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 924 (estimated) |
| Sponsor | Assistance Publique - Hôpitaux de Paris Academic / other |
| Locations | 1 site (Paris, Paris) |
| Status | Recruiting |
| Started | June 4, 2025 |
| Main results expected | June 2027 |
| Study ends | June 2027 |
| Registry record updated | July 17, 2026 |
| Trial ID | NCT06733974 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18) who are the patient's trusted relative or primary caregiver present when a patient is expected to die within 72 hours in the ED, who speak French and can complete phone follow-up, are ideal candidates.
✕Probably not a fit
Relatives who do not understand French, organ-donor relatives, those under legal protection or deprived of liberty, or those unable to complete follow-up are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional trial delivers a multifaceted support strategy to adult relatives of patients with an anticipated life expectancy under 72 hours in the ED at Pitié-Salpêtrière. The program combines targeted communication, emotional support, and structured follow-up contacts delivered during and after the ED stay. Participants give oral consent and are followed by phone interviews at 3 and 6 months to measure prolonged grief disorder and PTSD symptoms compared with usual care. Priority for enrollment is given to the patient's trusted person or the relative most involved in care, and non-French speakers or those who cannot be followed are excluded.
Why it matters
Potential benefit: If successful, the program could reduce the incidence or severity of prolonged grief disorder and PTSD among bereaved relatives after an in-ED death.
How similar studies have gone: Some ICU-based family support interventions have shown reductions in family distress, but multifaceted interventions specifically in ED settings are less well studied.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: \- Relative of a patient, that is dying in the ED, defined by an anticipated life expectancy of less than 72H with previous do not resuscitate order or treatment withholding. If several relative are present, participation to the trial will be offered in priority to the patient's trustworthy person, the relative most involved in the patient's care, the partner, a parent or child, another family member. * Age \>= 18 years * Agrees to be followed-up by phone interview at 3 and 6 months * Informed oral consent * Relative with health insurance (except AME). Exclusion Criteria: * Relative of a patient under 18 years of age * Relative who do not understand, read, or speak French * Relatives of organ donor patients (these relatives benefit from specific support and communication by the transplant coordination teams) * Inability to follow up * Participation in another intervention trial * Relative under legal protection (tutorship or curatorship) * Relative deprived of their liberty by a judicial or administrative decision * Relative physically unable to give his/her oral consent
Where it's running
-
Emergency Department Hospital Pitié-Salpêtrière
Paris, Paris, France Recruiting
Study contacts
- Principal investigator: Yonathan FREUND, PU-PH — Assistance Publique - Hôpitaux de Paris
- Study coordinator: Yonathan FREUND, PU-PH
- Email: yonathan.freund@aphp.fr
- Phone: +33663549017
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Support for families grieving an overdose loss
This project will test a peer-led grief support program called RIVER to help adults who lost a loved one to an unintentional drug overdose within the past year.
-
Diffusion MRI to map nerve lesions in obstetric brachial plexus palsy
This study tests diffusion MRI and tractography to better understand nerve injuries in people with obstetric brachial plexus palsy.
-
Long-term心理 and cognitive check after stem cell transplant for immune deficiencies
This study tests the long-term neurocognitive and psychological functioning of 6–8 year-old children who had an allogeneic stem cell transplant for a primary immune deficiency, at least two years after the transplant.
-
Benchmarking AI language models against tumor boards for oncology treatment decisions
This project tests whether frontier AI language models can match the treatment recommendations of multidisciplinary tumor boards for common cancers using standardized synthetic cases.
-
Gut microbes and autoinflammatory diseases: how they may be linked
This study tests whether gut bacteria and their byproducts relate to digestive and inflammatory symptoms in people with autoinflammatory diseases.
-
How Eye Dominance Affects Fusion in Healthy Adults
This study tests whether fusional vergence measurements differ when tested on the dominant eye versus the non-dominant eye in healthy adults.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.